Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL29652710 | 0.96 | — | — | |
| Glycine SCHEMBL582759 | 0.96 | — | — | |
| Glycine SCHEMBL699843 | 0.93 | — | — | |
| Glycine SCHEMBL445109 | 0.92 | — | — | |
| Glycine SCHEMBL5184981 | 0.92 | — | — | |
| Glycine SCHEMBL27542148 | 0.92 | — | — | |
| Glycine SCHEMBL3941221 | 0.92 | — | — | |
| Glycine SCHEMBL16038077 | 0.92 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL14697071 | 0.92 | — | — | |
| Glycine SCHEMBL2025188 | 0.92 | GLRA1 (0.83) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4366679-B1 | EMULSION ANTIPERSPIRANT COMPOSITIONS | UNILEVER IP HOLDINGS B V (NL) | 2025-04-16 | — | — | EP | claimed |
| EP-4366679-A1 | EMULSION ANTIPERSPIRANT COMPOSITIONS | Unilever IP Holdings B.V. (NL) | 2024-05-15 | — | — | EP | claimed |
| WO-2023280775-A1 | AQUEOUS ANTIPERSPIRANT COMPOSITIONS | UNILEVER IP HOLDINGS B.V. (NL) | 2023-01-12 | — | — | WO | claimed |
| WO-2023280776-A1 | EMULSION ANTIPERSPIRANT COMPOSITIONS | UNILEVER IP HOLDINGS B.V. (NL) | 2023-01-12 | — | — | WO | claimed |
| EP-4255386-B1 | ANTIPERSPIRANT COMPOSITIONS | UNILEVER IP HOLDINGS B V (NL) | 2025-03-26 | — | — | EP | disclosed |
| EP-4255382-B1 | ANTIPERSPIRANT COMPOSITIONS | UNILEVER IP HOLDINGS B V (NL) | 2025-02-26 | — | — | EP | disclosed |
| WO-2024248891-A1 | METHODS OF MAKING HIGH PERFORMANCE ALUMINUM-ZIRCONIUM ANTIPERSPIRANT ACTIVE POWDERS CONTAINING CALCIUM AND GLYCINE WITH LOW ZIRCONIUM CONTENT | GULBRANDSEN TECHNOLOGIES, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| EP-4366679-A1 | EMULSION ANTIPERSPIRANT COMPOSITIONS | Unilever IP Holdings B.V. (NL) | 2024-05-15 | — | — | EP | disclosed |
| US-20240091125-A1 | ANTIPERSPIRANT COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER | 2024-03-21 | — | — | US | disclosed |
| US-20240000690-A1 | ANTIPERSPIRANT COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER | 2024-01-04 | — | — | US | disclosed |
| EP-4255386-A1 | ANTIPERSPIRANT COMPOSITIONS | Unilever IP Holdings B.V. (NL) | 2023-10-11 | — | — | EP | disclosed |
| EP-4255382-A1 | ANTIPERSPIRANT COMPOSITIONS | Unilever IP Holdings B.V. (NL) | 2023-10-11 | — | — | EP | disclosed |
| EP-4031099-B1 | ANTIPERSPIRANT COMPOSITIONS | UNILEVER IP HOLDINGS B V (NL) | 2023-03-01 | — | — | EP | disclosed |
| WO-2023280776-A1 | EMULSION ANTIPERSPIRANT COMPOSITIONS | UNILEVER IP HOLDINGS B.V. (NL) | 2023-01-12 | — | — | WO | disclosed |
| US-20220339093-A1 | ANTIPERSPIRANT COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER | 2022-10-27 | — | — | US | disclosed |
| EP-4031099-A1 | ANTIPERSPIRANT COMPOSITIONS | Unilever IP Holdings B.V. (NL) | 2022-07-27 | — | — | EP | disclosed |
| EP-4025177-A1 | COMPOSITIONS CONTAINING DI-SUBSTITUTED TEREPHTHALATES AND LIGHT PROTECTION FILTER SUBSTANCES, DEODORANTS AND/OR ANTIPERSPIRANTS | Evonik Operations GmbH (DE) | 2022-07-13 | — | — | EP | disclosed |
| WO-2022122574-A1 | ANTIPERSPIRANT COMPOSITIONS | UNILEVER IP HOLDINGS B.V. (NL) | 2022-06-16 | — | — | WO | disclosed |
| WO-2022122385-A1 | ANTIPERSPIRANT COMPOSITIONS | UNILEVER IP HOLDINGS B.V. (NL) | 2022-06-16 | — | — | WO | disclosed |